Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 31;13(7):1327-1328.
doi: 10.21037/tau-24-16. Epub 2024 Jun 25.

Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial

Affiliations
Editorial

Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial

Srigita Madiraju et al. Transl Androl Urol. .
No abstract available

Keywords: Avelumab; JAVELIN; bladder cancer; maintenance; urothelial carcinoma (UC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-24-16/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Powles T, Park SH, Voog E, et al. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N Engl J Med 2020;383:1218-30. 10.1056/NEJMoa2002788 - DOI - PubMed
    1. Grivas P, Park SH, Voog E, et al. Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol 2023;84:95-108. 10.1016/j.eururo.2023.03.030 - DOI - PubMed
    1. Sonpavde GP, Mariani L, Lo Vullo S, et al. Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma. J Urol 2018;200:1207-14. 10.1016/j.juro.2018.07.035 - DOI - PMC - PubMed
    1. Grivas P, Agarwal N, Pal S, et al. Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice. Cancer Treat Rev 2021;97:102187. 10.1016/j.ctrv.2021.102187 - DOI - PubMed
    1. Sridhar SS, Powles T, Climent Durán MÁ, et al. Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance. Eur Urol 2024;85:154-63. 10.1016/j.eururo.2023.08.001 - DOI - PubMed

LinkOut - more resources